GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QSAM Biosciences Inc (OTCPK:QSAM) » Definitions » Shiller PE Ratio

QSAM Biosciences (QSAM Biosciences) Shiller PE Ratio : (As of May. 20, 2024)


View and export this data going back to 2011. Start your Free Trial

What is QSAM Biosciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


QSAM Biosciences Shiller PE Ratio Historical Data

The historical data trend for QSAM Biosciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QSAM Biosciences Shiller PE Ratio Chart

QSAM Biosciences Annual Data
Trend Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

QSAM Biosciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of QSAM Biosciences's Shiller PE Ratio

For the Biotechnology subindustry, QSAM Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QSAM Biosciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QSAM Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where QSAM Biosciences's Shiller PE Ratio falls into.



QSAM Biosciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

QSAM Biosciences's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, QSAM Biosciences's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-180/129.4194*129.4194
=-180.000

Current CPI (Dec. 2023) = 129.4194.

QSAM Biosciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.000 99.695 0.000
201406 -70.000 100.560 -90.090
201409 -220.000 100.428 -283.510
201412 0.000 99.070 0.000
201503 -70.000 99.621 -90.938
201506 -300.300 100.684 -386.007
201509 -18,619.200 100.392 -24,002.886
201512 0.000 99.792 0.000
201603 -93,506.400 100.470 -120,448.831
201606 28,727.900 101.688 36,562.268
201609 -28,334.500 101.861 -36,000.373
201612 -23,111.900 101.863 -29,364.313
201703 5,021.450 102.862 6,317.900
201706 -53,309.500 103.349 -66,757.074
201709 -12,322.800 104.136 -15,314.738
201712 -53,558.000 104.011 -66,641.389
201803 4,495.330 105.290 5,525.555
201806 -20,894.200 106.317 -25,434.502
201809 -41,271.600 106.507 -50,150.326
201812 39,493.600 105.998 48,220.182
201903 -20,574.600 107.251 -24,827.412
201906 -32,866.900 108.070 -39,359.990
201909 17,225.400 108.329 20,578.910
201912 7,488.360 108.420 8,938.740
202003 -15,918.500 108.902 -18,917.671
202006 -31,486.400 108.767 -37,464.854
202009 -82,400.000 109.815 -97,110.306
202012 -4,679.510 109.897 -5,510.801
202103 -17,520.000 111.754 -20,289.384
202106 -8,864.230 114.631 -10,007.758
202109 -4,413.750 115.734 -4,935.658
202112 -4,364.150 117.630 -4,801.565
202203 -2,222.870 121.301 -2,371.642
202206 -1,574.730 125.017 -1,630.186
202209 -1,330.880 125.227 -1,375.441
202212 -1,399.940 125.222 -1,446.868
202303 -1,800.000 127.348 -1,829.281
202306 -860.000 128.729 -864.614
202309 -720.000 129.860 -717.560
202312 -180.000 129.419 -180.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


QSAM Biosciences  (OTCPK:QSAM) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


QSAM Biosciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of QSAM Biosciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


QSAM Biosciences (QSAM Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
9442 Capital of Texas Highway North, Plaza 1, Suite 500, Austin, TX, USA, 78759
QSAM Biosciences Inc is a clinical-stage novel radiopharmaceutical company. The company is developing treatments for bone cancer and related diseases.
Executives
Adam King officer: Chief Financial Officer 9442 CAPITAL OF TEXAS HWY N, PLAZA 1, SUITE 500, AUSTIN TX 78759
Link Jr. Charles J director C/O NEWLINK GENETICS CORP., 2503 SOUTH LOOP DR., SUITE 5100, AIMES IA 50010
Adriann Sax director 7 DORSET COURT,, EAST BRUNSWICK, NJ 08816
David Charles Link director 2100 E 54TH STREET NORTH, SIOUX FALLS SD 57104
Douglas R Baum director, officer: CEO & Director 5000 RAFFEE COVE, AUSTIN TX 78731-1132
C Richard Piazza director, officer: Executive Chairman 2236 EAST MALL, SUITE 208, UNIVERSITY OF BRITISH COLUMBIA, VANCOUVER A1 V6T 1Z3
Checkmate Strategic Capital Holdings, Llc other: Member of 13(d) 10% owner grp 595 E. COLORADO BOULEVARD, SUITE 530, PASADENA CA 91101
Checkmate Strategic Capital 2, Llc 10 percent owner, other: See Explanation of Responses 595 E. COLORADO BOULEVARD, SUITE 530, PASADENA CA 91101
Checkmate Capital Group, Llc 10 percent owner, other: Member of 13(d) 10% owner grp 595 E. COLORADO BOULEVARD, SUITE 530, PASADENA CA 91101
Charles Thomas Paschall other: Member of 13(d) 10% owner grp 595 E. COLORADO BOULEVARD, SUITE 530, PASADENA CA 91101
Christopher M. Nelson director, officer: General Counsel 420 ROYAL PALM WAY, SUITE #100, PALM BEACH FL 33480
Scott W. Whitney director, other: Former Director 96 WINDSOR DRIVE, PINE BROOK NJ 07058
Kevin Bolin director, officer: Former Chairman & CEO 1081 ROSEDALE DRIVE, ATLANTA GA 30306
Tristan Peitz director, other: Former Director C/O Q2POWER TECHNOLOGIES, INC., 420 ROYAL PALM WAY, #100, PALM BEACH FL 33480
Joel David Mayersohn director 350 EAST LAS OLAS BLVD. #1150, FORT LAUDERDALE FL 33301

QSAM Biosciences (QSAM Biosciences) Headlines

From GuruFocus